Despite numerous treatment advances, chronic hepatitis B virus (HBV) infection remains a largely incurable disease impacting more than 290 million people worldwide. All patients with chronic HBV ...
Treatment with xalnesiran, a small interfering RNA molecule, plus an immunomodulator resulted in hepatitis B surface antigen loss among adults with chronic HBV infection, according to a study ...
The push to cure hepatitis B kicked off in earnest about 10 years ago, when several leading HBV scientists began convening scientific workshops aimed at developing a cure-focused action plan ...
advances in our understanding of hepatitis B virus (HBV) are helping to bring researchers closer to new solutions, namely a functional cure – that is, undetectable viral markers for a minimum of ...
Five more patients obtained virological response 24 weeks after the end of treatment. ‡Virological response in this study was defined as negative HBV DNA with normal aminotransferases and ...
and HBV DNA after 24 weeks' treatment to below the lower limit of detection in people with chronic hepatitis B, raising hopes that it could offer permanent cure, allowing safe termination of ...